Jiangxi Synergy Pharmaceutical Co., Ltd. (300636) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Jiangxi Synergy Pharmaceutical Co., Ltd.

Why is Jiangxi Synergy Pharmaceutical Co., Ltd. ?

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 11.61% and Operating profit at -8.79% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 6.92% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 11.61% and Operating profit at -8.79% over the last 5 years

Flat results in Mar 26

NET PROFIT(HY) At CNY 7.9 MM has Grown at -74.95%
OPERATING CASH FLOW(Y) Lowest at CNY 106.1 MM
ROCE(HY) Lowest at 3.02%

With ROE of 2.97%, it has a expensive valuation with a 0.49 Price to Book Value

Over the past year, while the stock has generated a return of -7.38%, its profits have fallen by -15.4%
At the current price, the company has a high dividend yield of 2.9

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -7.38% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Jiangxi Synergy Pharmaceutical Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Jiangxi Synergy Pharmaceutical Co., Ltd.

-7.38%

-0.97

29.27%

China Shanghai Composite

21.43%

1.55

13.83%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.61%

EBIT Growth (5y)

-8.79%

EBIT to Interest (avg)

10.67

Debt to EBITDA (avg)

3.53

Net Debt to Equity (avg)

0.24

Sales to Capital Employed (avg)

0.24

Tax Ratio

4.51%

Dividend Payout Ratio

22.99%

Pledged Shares

Institutional Holding

ROCE (avg)

4.82%

ROE (avg)

6.92%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.49

EV to EBIT

29.84

EV to EBITDA

10.67

EV to Capital Employed

0.57

EV to Sales

1.97

PEG Ratio

Dividend Yield

2.87%

ROCE (Latest)

1.92%

ROE (Latest)

2.97%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -17.13% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.09 times

-14What is not working for the Company

NET PROFIT(HY)

At CNY 7.9 MM has Grown at -74.95%

OPERATING CASH FLOW(Y)

Lowest at CNY 106.1 MM

ROCE(HY)

Lowest at 3.02%

NET SALES(Q)

Lowest at CNY 184.39 MM

Here's what is working for Jiangxi Synergy Pharmaceutical Co., Ltd.

Inventory Turnover Ratio

Highest at 1.09 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost

Fallen by -17.13% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiangxi Synergy Pharmaceutical Co., Ltd.

Net Profit

At CNY 7.9 MM has Grown at -74.95%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 106.1 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 184.39 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 184.39 MM has Fallen at -10.58%

over average net sales of the previous four periods of CNY 206.21 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)